Skip to main content
. Author manuscript; available in PMC: 2013 Mar 25.
Published in final edited form as: Hypertension. 2012 Nov 5;61(1):27–34. doi: 10.1161/HYPERTENSIONAHA.111.00100

Table 2. Hazard Ratios for Cardiovascular End Points in Relation to Clinic and Home Blood Pressure at Entry for the Whole Cohort and by Treatment Status.

Fatal and Nonfatal Cardiovascular End Points Combined
Blood pressure index Cardiovascular Death All Stroke Cardiac
All subjects (n=6470)
 End points, n 294 716 393 336
 Systolic blood pressure
  Clinic 1.11 (1.04–1.17) 1.09 (1.05–1.13)§ 1.12 (1.06–1.17)§ 1.05 (1.00–1.11)
  Home 1.13 (1.05–1.21) 1.19 (1.14–1.25)§ 1.28 (1.20–1.37)§ 1.10 (1.03–1.18)
 Diastolic blood pressure
  Clinic 1.05 (1.00–1.11) 1.07 (1.04–1.11)§ 1.09 (1.04–1.14) 1.04 (0.99–1.10)
  Home 1.04 (0.97–1.11) 1.13 (1.08–1.17)§ 1.19 (1.13–1.25)§ 1.05 (0.99–1.12)
Treated (n=1452)
 End points, n 136 302 168 142
 Systolic blood pressure
  Clinic 1.02 (0.93–1.11) 1.01 (0.96–1.07) 1.07 (0.99–1.16) 0.94 (0.86–1.02)
  Home 1.16 (1.04–1.29) 1.15 (1.08–1.24)§ 1.31 (1.18–1.45)§ 1.03 (0.93–1.14)
 Diastolic blood pressure
  Clinic 1.00 (0.93–1.08) 1.03 (0.98–1.08) 1.04 (0.97–1.11) 1.00 (0.92–1.08)
  Home 1.07 (0.97–1.19) 1.11 (1.04–1.17) 1.19 (1.10–1.29)§ 1.00 (0.91–1.11)
Untreated (n=5018)
 End points, n 158 414 225 194
 Systolic blood pressure
  Clinic 1.19 (1.10–1.28)§ 1.15 (1.09–1.20)§ 1.15 (1.08–1.23)§ 1.15 (1.07–1.23)
  Home 1.10 (1.00–1.21) 1.21 (1.14–1.28)§ 1.26 (1.16–1.37)§ 1.16 (1.06–1.26)
 Diastolic blood pressure
  Clinic 1.10 (1.02–1.18)* 1.11 (1.06–1.16)§ 1.13 (1.07–1.20)§ 1.08 (1.00–1.15)*
  Home 1.00 (0.91–1.09) 1.14 (1.08–1.20)§ 1.18 (1.09–1.27)§ 1.08 (1.00–1.18)

Hazard ratios (95% CIs) reflect the risk associated with 10- and 5-mm Hg increases in systolic and diastolic blood pressure, respectively. Hazard ratios were adjusted for cohort, sex, age, body mass index, smoking, history of cardiovascular disease, diabetes mellitus, treatment with antihypertensive drugs, and serum total cholesterol. The associations between clinic systolic blood pressure and cardiovascular end points were markedly steeper in the untreated as compared with the treated population (P<0.05 for all comparisons).

Significance of the hazard ratios:

*

P≤0.05;

P≤0.01;

P≤0.001;

§

P≤0.0001.